Panacea Biotec Limited (PANACEABIO) Stock Statistics & Valuation Metrics

Panacea Biotec Limited has a market cap or net worth of ₹26.66B. The enterprise value is ₹26.12B.

Panacea Biotec Limited has 61,250,744 shares outstanding. The number of shares has decreased by -2.65% in one year.

Panacea Biotec Limited’s return on equity (ROE) is -0.01 and return on invested capital (ROIC) is -7.22%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Panacea Biotec Limited had revenue of 5.59B and earned -83.70M in profits. Earnings per share was -1.37.

In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.

Panacea Biotec Limited pays an annual dividend of ₹0.75, resulting in a dividend yield of ―

Panacea Biotec Limited upcoming earnings date is ―, ―.

Panacea Biotec Limited as a current ratio of 1.49, with Debt / Equity ratio of 2.66%

In the past 12 months, Panacea Biotec Limited has paid 7.70M in taxes.

Panacea Biotec Limited EV to EBITDA ratio is 87.91, with an EV/FCF ratio of -34.79.

Panacea Biotec Limited has ₹1.77B in cash and marketable securities with ₹0.00 in debt, giving a net cash position of -₹1.77B billion.

Gross margin is 56.04%, with operating margin of -10.86%, and net profit margin of -1.50%.

The average price target for Panacea Biotec Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―